Forging Win-Win Collaborations in Healthcare: Interview with Reimagine Care CEO Dan Nardi

episode

Scott Nelson Live not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

More from Scott Nelson Live

The Hidden Drivers of Clinical Trial Success: Interview with Rivermark CEO Dr. Adam Kadlec 57 min · 16 Dec 2025

Building the Market Before the Product: Interview with Inmedix CEO Andrew Holman, MD 52 min · 10 Dec 2025

All episodes from Scott Nelson Live →

Report any issue

Source

Recorded17 Jul 2024

Publisherfeeds.transistor.fm ↗

Handlerec:13866246

Show notes

In this episode of Medsider Radio, we had an insightful chat with Dan Nardi, CEO of Reimagine Care, a startup that integrates clinical oncology experts and robust capabilities to deliver individualized cancer treatment and recovery experience from home.Dan has over two decades of experience in healthcare IT and digital health. Before Reimagine Care, he served as COO at Carrum Health, where he focused on value-based care and oversaw operations, including care delivery and growth. He also played a key role in scaling Livongo from 13 employees to its IPO as Vice President of Operations. In this interview, Dan shares how he forms strategic partnerships that prioritize long-term value over short-term gains, how to leverage early adopters, and how he’s positioned his company in the emerging fee-for-value healthcare model.Before we dive into the discussion, I wanted to mention a few things:First, if you’re into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership. You’ll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more!We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks, which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and a curated investor database to help you discover your next medical device or health technology investor!In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost, including the latest Medsider Mentors Volume VI. If you’re interested, go to medsider.com/subscribe to learn more.Lastly, if you'd rather read than listen, here's a link to the full interview with Dan Nardi.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.